A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

UC Davis Comprehensive Cancer Center is testing a drug called niraparib (ZEJULA), given before prostate cancer surgery.

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

Social media can push vulnerable young people toward developing eating disorders by glorifying thinness and promoting fake, ...

Stress from work doesn't always stay at the office—and it may be affecting more than just your mood. A new study finds that ...

French scientist Etienne-Emile Baulieu, the inventor of the abortion pill, died at the age of 98 at his home in Paris on ...

Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious ...

Smoke from Canada wildfires is rapidly drifting into the U.S. and the American Heart Association, a global force changing the ...

People who are at higher risk for heart disease also seem more likely to develop dementia. And research led by The University ...

The New South Wales government this week announced reforms that will allow some general practitioners (GPs) to treat and ...

Statisticians from the National University of Singapore (NUS) have developed a pioneering approach for analyzing ...

Over 10 million infants under six months old may currently be underweight, according to a new analysis of data collected ...